Satisfaction, Safety and Cost of the Treatment for Multiple Sclerosis Relapse with Intravenous versus Oral Methylprednisolone
Introduction: Relapse is a clinical indication of MS activity. Treatment with corticosteroids is recommended for anti-inflammatory, immunosuppressive effects and reduction in the duration and intensity of symptoms. The dosage of intravenous methylprednisolone (ivMP) is 500-1000 mg daily and that of...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Mashhad University of Medical Sciences
2018-10-01
|
Series: | Patient Safety and Quality Improvement Journal |
Subjects: | |
Online Access: | http://psj.mums.ac.ir/article_11702_d41d8cd98f00b204e9800998ecf8427e.pdf |